GlassScriptPhysician profile
Chandra L Brown
NPI 1770523821
$8,204.32
in general payments reported to CMS, 2019-2025
49 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,450 · 2020: $773 · 2021: $1,148 · 2022: $1,478 · 2023: $1,504 · 2024: $752 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,355.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,608.95 | 2019-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $1,410.03 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $602.69 | 2021-2025 | Qulipta, Vraylar, Linzess |
| Glaxosmithkline, LLC. | $406.36 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $389.06 | 2019-2024 | Belsomra, Steglatro, Capvaxive |
| Astellas Pharma US INC | $339.13 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $339.01 | 2019-2025 | Kisunla, Jardiance, Emgality |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $306.26 | 2019-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $259.30 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.54 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $208.16 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $160.43 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.32 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $156.85 | 2019-2023 | Austedo Xr, Austedo |
| Amarin Pharma, INC. | $145.65 | 2019-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $139.79 | 2019-2025 | |
| Abbott Laboratories | $122.10 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Genentech USA, INC. | $114.14 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $75.89 | 2021 | |
| Eisai INC. | $69.65 | 2019-2020 | |
| Medtronic, INC. | $64.93 | 2022-2025 | Intellis Adaptivestim, O-Arm, Venaseal |
| Almatica Pharma LLC | $63.67 | 2023-2024 | Loreev Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $61.69 | 2022 | |
| Dexcom, INC. | $57.80 | 2024-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $56.96 | 2021-2022 | |
| Radius Health, INC. | $49.43 | 2019-2023 | Tymlos |
| Takeda Pharmaceuticals U.S.A., INC. | $43.28 | 2019 | |
| Sunovion Pharmaceuticals INC. | $41.74 | 2022 | |
| Corcept Therapeutics | $40.24 | 2025 | Korlym |
| Kowa Pharmaceuticals America, INC. | $36.28 | 2019-2021 | |
| Esperion Therapeutics, INC. | $35.88 | 2020-2021 | |
| Shire North American Group INC | $33.65 | 2019 | |
| Beta Bionics, INC. | $31.20 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Exact Sciences Corporation | $30.46 | 2023-2024 | Cologuard Collection Kit |
| Vivus LLC | $28.37 | 2022-2023 | Qsymia |
| Medtronic Minimed, INC. | $26.64 | 2019 | |
| Sumitomo Pharma America, INC. | $26.62 | 2023 | Gemtesa |
| Ethicon US, LLC | $25.35 | 2021 | |
| Medtronic USA, INC. | $21.37 | 2019 | |
| Boston Scientific Corporation | $20.72 | 2019 | |
| Seqirus USA INC | $19.17 | 2025 | Flucelvax, Fluad |
| Antares Pharma, INC. | $18.85 | 2025 | Xyosted |
| Verity Pharmaceuticals INC. | $18.68 | 2025 | Tlando |
| Renalytix Ai, INC. | $17.53 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Arbor Pharmaceuticals, INC. | $16.53 | 2021 | |
| Philips North America LLC | $15.77 | 2024 | (Ck7) Extended Holter |
| Amneal Pharmaceuticals LLC | $14.35 | 2021 | |
| Currax Pharmaceuticals LLC | $13.53 | 2021 | |
| Therapeuticsmd, INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.